Currently the price of heart stents is capped in India at INR 30,000 and all companies are selling their basic drug eluting stents at or under that price.

If a premium category and corresponding price cap is created for stents like the previous poll's finding suggests, should there be a requirement for any company listing its product in this category to have a product in the basic category on a mandatory basis?

Viewed by 8202

Related Polls

Enter your email & mobile number and we will send you the instructions

Note - The email can sometime gets delivered to the spam folder, so the instruction will be send to your mobile as well

Please select a Circle that you want people to invite to.
Invite to
(Maximum 500 email ids allowed.)